¼¼°èÀÇ °æÈ­¿ä¹ý ½ÃÀå º¸°í¼­(2025³â)
Sclerotherapy Global Market Report 2025
»óǰÄÚµå : 1760708
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,233,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,010,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,786,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

°æÈ­¿ä¹ý ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2029³â±îÁö CAGR 6.4%·Î 15¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¼ºÀåÀº ÃÖ¼Òħ½ÀÀû ½Ã¼úÀÇ Ã¤Åà Áõ°¡, ¸¸¼º Á¤¸Æ ÁúȯÀÇ À¯º´·ü Áõ°¡, ¹Ì¿ë Á¤¸Æ Ä¡·á¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, Á¤¸Æ Àü¹® Ŭ¸®´Ð¿¡ ´ëÇÑ Á¢±Ù¼º È®´ë, ½ÅÈï ½ÃÀåÀÇ ÀÇ·áºñ ÁöÃâ Áõ°¡, ¿Ü·¡ ȯÀÚ Ä¡·á¸¦ ÃËÁøÇÏ´Â ÁöÁöÀûÀÎ ±ÔÁ¦ ÀÌ´Ï¼ÅÆ¼ºê¿Í °ü·ÃÀÌ ÀÖÀ» ¼ö ÀÖ½À´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ÁÖ¿ä µ¿ÇâÀ¸·Î´Â Æû ±â¹Ý Á¦Á¦ °³¹ß, ÃÊÀ½ÆÄ À¯µµ ±â¼ú ÅëÇÕ, ÃÖ¼Òħ½ÀÀû ½Ã¼úÀÇ Ã¤ÅÃ, ¸ÂÃãÇü Ä¡·á °èȹ °³¹ß, Áø´Ü Á¤È®µµ¸¦ À§ÇÑ AI »ç¿ë, ½Ã¼ú ÈÄ È¸º¹ ÇÁ·ÎÅäÄÝ °­È­, ¿Ü·¡ Á¤¸Æ Ŭ¸®´ÐÀÇ È®´ë µîÀÌ ÀÖ½À´Ï´Ù.

ÇÏÁöÁ¤¸Æ·ù¿Í °Å¹ÌÁÙ Á¤¸ÆÀÇ À¯º´·ü Áõ°¡´Â °æÈ­¿ä¹ý ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÇÏÁöÁ¤¸Æ·ù¿Í °Å¹ÌÁÙ Á¤¸ÆÀº ÇǺΠ¾Æ·¡¿¡¼­ º¼ ¼ö ÀÖ´Â È®ÀåµÇ°Å³ª ²¿À̰ųª ¼Õ»óµÈ Á¤¸ÆÀ¸·Î, ÁÖ·Î ´Ù¸®ÀÇ Ç÷¾×¼øÈ¯ Àå¾Ö·Î ÀÎÇØ ¹ß»ýÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Á¤¸Æ·ùÀÇ Áõ°¡´Â Çö´ëÀÎÀÇ »ýȰ½À°ü¿¡ ±âÀÎÇÏ´Â ¹Ù°¡ Å«µ¥, ¾÷¹«»ó ½À°üÀ¸·Î ÀÎÇØ Àå½Ã°£ ¾É¾ÆÀְųª ¼­ ÀÖ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. °æÈ­¿ä¹ýÀº ¼Õ»óµÈ Á¤¸ÆÀ» ¸·°í Ç÷·ù¸¦ °³¼±Çϸç ÇǺΠ¿Ü°üÀ» °³¼±ÇÏ´Â ¿ë¾×À» Ç¥Àû ÁÖ»çÇÏ¿© ÀÌ ¹®Á¦¸¦ ÇØ°áÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 1¿ù ±¹¸³ »ý¹° °øÇÐ Á¤º¸ ¼¾ÅÍ(NCBI)°¡ ¹ßÇ¥ÇÑ º¸°í¼­¿¡ µû¸£¸é ºê¶óÁú Àα¸ÀÇ 47.6%°¡ Á¤¸Æ·ù·Î °íÅë ¹Þ°í ÀÖÀ¸¸ç, ³²¼º(37.9 %)¿¡ ºñÇØ ¿©¼ºÀÇ À¯º´·ü(50.9 %)ÀÌ ´õ ³ô½À´Ï´Ù. ÀÌó·³ Á¤¸Æ·ù ¹× °Å¹ÌÁÙ Á¤¸ÆÀÇ ¹ß»ýÀÌ Áõ°¡ÇÔ¿¡ µû¶ó °æÈ­¿ä¹ý ½ÃÀåÀÇ ¼ºÀåÀ» Å©°Ô ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÇコÄɾî ÁöÃâÀÇ Áõ°¡´Â °æÈ­¿ä¹ý ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÇコÄɾî ÁöÃâÀº ±¹°¡ ¹× ÀÇ·á ½Ã½ºÅÛ¿¡¼­ ÀÇ·á ¼­ºñ½º, Ä¡·á ¹× °Ç°­ °ü·Ã ÀÚ¿ø¿¡ ´ëÇÑ ÃÑ ÁöÃâÀ» ÀǹÌÇÕ´Ï´Ù. ÇコÄɾî ÁöÃâÀÇ Áõ°¡´Â Áø´Ü°ú Ä¡·á¸¦ °³¼±ÇÏ´Â ÇÑÆí, °³¹ß, Àåºñ, Àü¹® Àη¿¡ ´ëÇÑ ¸·´ëÇÑ ÅõÀÚ¸¦ ÇÊ¿ä·Î Çϴ ÷´Ü ÀÇ·á ±â¼úÀÇ ºñ¿ë Áõ°¡°¡ ÁÖ¿ä ¿øÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀçÁ¤Àû Áö¿øÀº °æÈ­¿ä¹ý°ú °°Àº Àü¹®Ä¡·á¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» ³ôÀ̰í, ÀÇ·áÁø ¹× ÷´Ü Àåºñ¸¦ È®º¸ÇÒ ¼ö ÀÖ°Ô ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, ¿µ±¹ Åë°èûÀÌ 2024³â 5¿ù¿¡ ¹ßÇ¥ÇÑ ¹Ù¿¡ µû¸£¸é 2024³â ¿µ±¹ÀÇ ÀÇ·áºñ ÁöÃâÀº ¾à 4,213¾ï 2,000¸¸ ´Þ·¯(3,170¾ï ÆÄ¿îµå)·Î 2023³â ´ëºñ 6.5% Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óÇß½À´Ï´Ù. µû¶ó¼­ ÀÇ·áºñ ÁöÃâ Áõ°¡ Ãß¼¼´Â Áö¼ÓµÉ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÀÌ´Â °æÈ­¿ä¹ý ½ÃÀåÀÇ ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ª ÀüÀï°ú °ü¼¼, Äڷγª¿Í ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷°ú Çõ½ÅÀû ±â¾÷

Á¦32Àå ¼¼°èÀÇ ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´

Á¦34Àå ÃÖ±ÙÀÇ ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, Àü·«

Á¦36Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Sclerotherapy is a minimally invasive procedure used to treat varicose and spider veins by injecting a concentrated solution (sclerosant) directly into the affected veins. The sclerosant irritates the vein lining, causing it to collapse, scar, and eventually be reabsorbed by the body. Over time, the treated veins fade, and blood flow is redirected through healthier vessels.

The main types of sclerotherapy are liquid sclerotherapy, foam sclerotherapy, and ultrasound-guided sclerotherapy. Liquid sclerotherapy involves injecting a solution into the affected veins and is used to treat varicose and spider veins. The procedure employs various agents, including detergents, chemical irritants, and osmotic agents. These are used for applications such as varicose veins, spider veins, and hemorrhoids, serving various end users such as hospitals, ambulatory surgical centers, specialty clinics, and others.

The sclerotherapy market research report is one of a series of new reports from The Business Research Company that provides sclerotherapy market statistics, including the sclerotherapy industry global market size, regional shares, competitors with the sclerotherapy market share, detailed sclerotherapy market segments, market trends, and opportunities, and any further data you may need to thrive in the sclerotherapy industry. This sclerotherapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The sclerotherapy market size has grown strongly in recent years. It will grow from $1.14 billion in 2024 to $1.22 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth during the historic period can be attributed to the rising prevalence of varicose veins, an increasing aging population, growing demand for minimally invasive procedures, improved healthcare infrastructure, greater awareness of aesthetic treatments, and expanding insurance coverage for vein-related conditions.

The sclerotherapy market size is expected to see strong growth in the next few years. It will grow to $1.56 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The growth during the forecast period can be linked to the increasing adoption of minimally invasive procedures, the rising prevalence of chronic venous disorders, growing awareness of cosmetic vein treatments, expanding access to specialized vein clinics, increased healthcare expenditure in emerging markets, and supportive regulatory initiatives promoting outpatient treatments. Key trends in the forecast period include advancements in foam-based formulations, integration of ultrasound-guided techniques, adoption of minimally invasive procedures, development of personalized treatment plans, use of AI for diagnostic precision, enhanced post-procedure recovery protocols, and the expansion of outpatient vein clinics.

The growing prevalence of varicose veins and spider veins is anticipated to drive the expansion of the sclerotherapy market. Varicose and spider veins are enlarged, twisted, or damaged veins that are visible under the skin, primarily caused by poor blood circulation, particularly in the legs. This rise in prevalence is largely attributed to modern lifestyles, where people spend long hours sitting or standing, often due to work-related habits. Sclerotherapy addresses this issue by using targeted injections of a solution that seals off damaged veins, improving blood flow and the appearance of the skin. For example, a January 2024 report from the National Center for Biotechnology Information (NCBI) noted that in Brazil, 47.6% of the population suffered from varicose veins, with women having a higher prevalence (50.9%) compared to men (37.9%). As such, the increasing occurrence of varicose and spider veins is expected to significantly boost the growth of the sclerotherapy market.

The rising healthcare expenditure is driving the growth of the sclerotherapy market. Healthcare expenditure refers to the total spending on medical services, treatments, and health-related resources within a country or healthcare system. The rise in healthcare spending is largely attributed to the increasing costs of advanced medical technologies, which, while improving diagnosis and treatment, require substantial investment in development, equipment, and specialized personnel. This financial support enhances access to specialized treatments such as sclerotherapy, ensuring availability of medical staff and cutting-edge equipment. For instance, the Office for National Statistics in the UK reported in May 2024 that healthcare expenditure in the UK reached approximately $421.32 billion (£317 billion) in 2024, marking a 6.5% increase compared to 2023. Therefore, the upward trend in healthcare expenditure is expected to continue fueling the growth of the sclerotherapy market.

Major companies in the sclerotherapy market are forming strategic partnerships to enhance their research capabilities and broaden their product offerings. These collaborations aim to strengthen their presence through shared expertise and global distribution networks. Advanced, minimally invasive treatments for varicose veins, such as sclerotherapy, laser therapy, and radiofrequency ablation, offer effective solutions to close or remove damaged veins with minimal pain, quick recovery, and fewer complications. For example, in February 2025, Aakash Healthcare, a specialty hospital in India, partnered with Medtronic plc, a US-based healthcare company, to launch a specialized vein clinic. This clinic offers advanced, minimally invasive treatments for varicose veins and other vein-related conditions, providing patients with faster recovery and long-term health benefits. Additionally, the clinic offers personalized treatment plans and post-treatment care, ensuring a comprehensive approach to vein health and overall well-being.

Major players in the sclerotherapy market are Bayer AG, Sanofi S.A., Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Medtronic plc, Boston Scientific Corporation, Olympus Corporation, Smith & Nephew plc, Teleflex Incorporated, Cook Medical, Merz Pharma GmbH & Co. KGaA, AngioDynamics Inc., Bioniche Pharma Group Ltd, Omega Pharmaceuticals Pvt. Ltd., Endo-Flex, Kreussler, Vascular Solutions, Inc., LGM Pharma, BTG International Ltd.

North America was the largest region in the sclerotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sclerotherapy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the sclerotherapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sclerotherapy market consists of revenues earned by entities by providing services such as spider vein removal, cosmetic vein treatment. The market value includes the value of related goods sold by the service provider or included within the service offering. The sclerotherapy market also includes sales of polidocanol asclera, hypertonic saline, sodium tetradecyl sulfate. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified.

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sclerotherapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sclerotherapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for sclerotherapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sclerotherapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Sclerotherapy Market Characteristics

3. Sclerotherapy Market Trends And Strategies

4. Sclerotherapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Sclerotherapy Growth Analysis And Strategic Analysis Framework

6. Sclerotherapy Market Segmentation

7. Sclerotherapy Market Regional And Country Analysis

8. Asia-Pacific Sclerotherapy Market

9. China Sclerotherapy Market

10. India Sclerotherapy Market

11. Japan Sclerotherapy Market

12. Australia Sclerotherapy Market

13. Indonesia Sclerotherapy Market

14. South Korea Sclerotherapy Market

15. Western Europe Sclerotherapy Market

16. UK Sclerotherapy Market

17. Germany Sclerotherapy Market

18. France Sclerotherapy Market

19. Italy Sclerotherapy Market

20. Spain Sclerotherapy Market

21. Eastern Europe Sclerotherapy Market

22. Russia Sclerotherapy Market

23. North America Sclerotherapy Market

24. USA Sclerotherapy Market

25. Canada Sclerotherapy Market

26. South America Sclerotherapy Market

27. Brazil Sclerotherapy Market

28. Middle East Sclerotherapy Market

29. Africa Sclerotherapy Market

30. Sclerotherapy Market Competitive Landscape And Company Profiles

31. Sclerotherapy Market Other Major And Innovative Companies

32. Global Sclerotherapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sclerotherapy Market

34. Recent Developments In The Sclerotherapy Market

35. Sclerotherapy Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â